← Back to headlines
Novo Nordisk to Seek Chinese Approval for Weight-Loss Pill
Novo Nordisk is reportedly preparing to follow Lilly in seeking regulatory approval in China for its weight-loss medication.
17 Jun, 15:24 — 17 Jun, 15:24
Sources
Showing 1 of 1 sources
